Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
- Journal
- PubMed
In The Last Decade
doi.org/w53915813 →Countries where authors are citing Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
This map shows the geographic impact of Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. more than expected).
Fields of papers citing Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
This network shows the impact of Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype..
About Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
This paper, published in 1998, received 508 indexed citations . Written by Clara D. Bloomfield, David Lawrence, John C. Byrd, Andrew J. Carroll, Mark J. Pettenati, Ramana Tantravahi, S. Patil, Frederick R. Davey, Deborah Berg and Charles A. Schiffer covering the research area of Molecular Biology, Genetics and Hematology. It is primarily cited by scholars working on Hematology (481 citations), Molecular Biology (211 citations) and Public Health, Environmental and Occupational Health (192 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w53915813.